JP2001513080A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001513080A5 JP2001513080A5 JP1998535034A JP53503498A JP2001513080A5 JP 2001513080 A5 JP2001513080 A5 JP 2001513080A5 JP 1998535034 A JP1998535034 A JP 1998535034A JP 53503498 A JP53503498 A JP 53503498A JP 2001513080 A5 JP2001513080 A5 JP 2001513080A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (27)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79634197A | 1997-02-07 | 1997-02-07 | |
| US08/797,817 US6060513A (en) | 1997-02-07 | 1997-02-07 | Compounds and compositions for delivering active agents |
| US08/796,335 | 1997-02-07 | ||
| US08/797,813 | 1997-02-07 | ||
| US08/797,816 US6090958A (en) | 1995-03-31 | 1997-02-07 | Compounds and compositions for delivering active agents |
| US08/797,100 US6313088B1 (en) | 1997-02-07 | 1997-02-07 | 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents |
| US08/797,817 | 1997-02-07 | ||
| US08/796,335 US5876710A (en) | 1997-02-07 | 1997-02-07 | Compounds and compositions for delivering active agents |
| US08/796,339 US5804688A (en) | 1997-02-07 | 1997-02-07 | Compounds and compositions for delivering active agents |
| US08/796,334 | 1997-02-07 | ||
| US08/796,338 | 1997-02-07 | ||
| US08/796,334 US5879681A (en) | 1997-02-07 | 1997-02-07 | Compounds and compositions for delivering active agents |
| US08/797,813 US6051561A (en) | 1997-02-07 | 1997-02-07 | Compounds and compositions for delivering active agents |
| US08/796,336 US6358504B1 (en) | 1997-02-07 | 1997-02-07 | Compounds and compositions for delivering active agents |
| US08/797,820 | 1997-02-07 | ||
| US08/796,338 US5776888A (en) | 1997-02-07 | 1997-02-07 | Compounds and compositions for delivering active agents |
| US08/796,337 US5773647A (en) | 1997-02-07 | 1997-02-07 | Compounds and compositions for delivering active agents |
| US08/796,340 US5939381A (en) | 1997-02-07 | 1997-02-07 | Compounds and compositions for delivering active agents |
| US08/796,341 | 1997-02-07 | ||
| US08/796,340 | 1997-02-07 | ||
| US08/796,336 | 1997-02-07 | ||
| US08/796,337 | 1997-02-07 | ||
| US08/797,820 US5990166A (en) | 1997-02-07 | 1997-02-07 | Compounds and compositions for delivering active agents |
| US08/796,339 | 1997-02-07 | ||
| US08/797,816 | 1997-02-07 | ||
| US08/797,100 | 1997-02-07 | ||
| PCT/US1998/002619 WO1998034632A1 (en) | 1997-02-07 | 1998-02-06 | Compounds and compositions for delivering active agents |
Related Child Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000311231A Division JP3964613B2 (ja) | 1997-02-07 | 2000-10-11 | 化合物及び活性剤を送達するための組成物 |
| JP2000311230A Division JP4012679B2 (ja) | 1997-02-07 | 2000-10-11 | 化合物及び活性剤を送達するための組成物 |
| JP2009246865A Division JP5215977B2 (ja) | 1997-02-07 | 2009-10-27 | 化合物及び活性剤を送達するための組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001513080A JP2001513080A (ja) | 2001-08-28 |
| JP2001513080A5 true JP2001513080A5 (https=) | 2007-06-07 |
| JP4975201B2 JP4975201B2 (ja) | 2012-07-11 |
Family
ID=27584608
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53503498A Expired - Fee Related JP4975201B2 (ja) | 1997-02-07 | 1998-02-06 | 化合物及び活性剤を送達するための組成物 |
| JP2000311231A Expired - Fee Related JP3964613B2 (ja) | 1997-02-07 | 2000-10-11 | 化合物及び活性剤を送達するための組成物 |
| JP2000311230A Expired - Fee Related JP4012679B2 (ja) | 1997-02-07 | 2000-10-11 | 化合物及び活性剤を送達するための組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000311231A Expired - Fee Related JP3964613B2 (ja) | 1997-02-07 | 2000-10-11 | 化合物及び活性剤を送達するための組成物 |
| JP2000311230A Expired - Fee Related JP4012679B2 (ja) | 1997-02-07 | 2000-10-11 | 化合物及び活性剤を送達するための組成物 |
Country Status (9)
| Country | Link |
|---|---|
| EP (3) | EP1015008B1 (https=) |
| JP (3) | JP4975201B2 (https=) |
| AT (2) | ATE383169T1 (https=) |
| CA (3) | CA2319672C (https=) |
| DK (2) | DK1093819T3 (https=) |
| ES (2) | ES2297909T3 (https=) |
| NZ (3) | NZ337131A (https=) |
| PT (1) | PT1093819E (https=) |
| WO (1) | WO1998034632A1 (https=) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL126318A (en) | 1996-03-29 | 2004-09-27 | Emisphere Tech Inc | Compounds and compositions for delivering active agents and some novel carrier compounds |
| AU728523C (en) | 1996-10-21 | 2001-08-09 | Nps Pharmaceuticals, Inc. | Neurotrophin antagonist compositions |
| US6358504B1 (en) | 1997-02-07 | 2002-03-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| EP1676832A3 (en) * | 1998-08-07 | 2006-09-06 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| IL140930A0 (en) * | 1998-08-07 | 2002-02-10 | Emisphere Tech Inc | Compounds and compositions for delivering active agents |
| AU3357800A (en) | 1999-02-05 | 2000-08-25 | Emisphere Technologies, Inc. | Method of preparing alkylated salicylamides |
| ES2235854T3 (es) * | 1999-04-05 | 2005-07-16 | Emisphere Technologies, Inc. | Sales disodicas, monohidratos y solvatos etanolicos para aportar agentes activos. |
| US6468990B1 (en) * | 1999-05-17 | 2002-10-22 | Queen's University At Kingston | Method of inhibiting binding of nerve growth factor to p75 NTR receptor |
| US6492380B1 (en) | 1999-05-17 | 2002-12-10 | Queen's University At Kingston | Method of inhibiting neurotrophin-receptor binding |
| EP1748046A3 (en) | 1999-11-23 | 2007-08-22 | Methylgene, Inc. | Inhibitors of histone deacetylase |
| US7151191B2 (en) | 2000-01-13 | 2006-12-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US6900344B2 (en) * | 2000-03-21 | 2005-05-31 | Emisphere Technologies, Inc. | Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| WO2001083427A1 (en) * | 2000-04-28 | 2001-11-08 | Sankyo Company, Limited | PPARη MODULATORS |
| ES2306719T3 (es) * | 2000-06-29 | 2008-11-16 | Emisphere Technologies, Inc. | Compuestos y composiciones para la administracion de principios activos. |
| WO2002015959A2 (en) * | 2000-08-18 | 2002-02-28 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US7049283B2 (en) | 2000-12-06 | 2006-05-23 | Novartis Ag | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| JP5073153B2 (ja) | 2001-06-01 | 2012-11-14 | ノバルティス アーゲー | 副甲状腺ホルモンおよびカルシトニンの経口投与 |
| SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
| KR20040030120A (ko) * | 2001-08-17 | 2004-04-08 | 노파르티스 아게 | 부갑상선 호르몬 단편의 경구 전달제로서의 5-cnac |
| WO2003035602A1 (en) * | 2001-10-25 | 2003-05-01 | Sankyo Company, Limited | Lipid modulators |
| CA2466863A1 (en) * | 2001-11-29 | 2003-06-05 | Emisphere Technologies, Inc. | Oral pharmaceutical compositions comprising cromolyn sodium and an acylated amino acid |
| EP1469827B1 (en) * | 2002-01-09 | 2017-12-27 | Emisphere Technologies, Inc. | Polymorphs of sodium 4- (4-chloro-2-hydroxybenzoyl)amino butanoate |
| PL209734B1 (pl) * | 2002-02-20 | 2011-10-31 | Emisphere Tech Inc | Preparat farmaceutyczny zawierający związek GLP-1 i czynnik dostarczający oraz jego zastosowanie |
| TW200403052A (en) * | 2002-07-17 | 2004-03-01 | Novartis Ag | Use of organic compounds |
| CN1506359A (zh) * | 2002-12-05 | 2004-06-23 | �й�ҽѧ��ѧԺҩ���о��� | 新的香豆素酰胺衍生物及其制法和其药物组合物与用途 |
| BRPI0411165A (pt) * | 2003-05-14 | 2006-07-11 | Emisphere Tech Inc | composição farmacêutica, forma de unidade de dosagem e métodos para preparar seu uso |
| EP1641486B1 (en) * | 2003-06-10 | 2012-04-18 | LG Life Sciences Ltd. | Stable, aqueous solution of human erythropoietin, not containing serum albumin |
| ATE350369T1 (de) * | 2003-08-20 | 2007-01-15 | Lilly Co Eli | Verbindungen, verfahren und formulierungen zur oralen verabreichung einer glucagon like peptide (glp)-1-verbindung oder eines am melanocortin-4- rezeptor (mc4) als agonist wirkenden peptids |
| EP1658285B1 (en) * | 2003-08-20 | 2007-05-02 | Eli Lilly And Company | Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| MXPA06013252A (es) * | 2004-05-14 | 2007-02-28 | Emisphere Tech Inc | Compuestos y composiciones para suministrar agentes activos. |
| BRPI0510820A (pt) | 2004-05-19 | 2007-11-27 | Emisphere Tech Inc | composição farmacêutica, forma unitária de dosagem e seus usos |
| CN1968704B (zh) * | 2004-05-19 | 2010-12-08 | 爱密斯菲尔科技公司 | 局部用色甘酸制剂 |
| MX2007000510A (es) * | 2004-07-12 | 2007-03-29 | Emisphere Tech Inc | Composiciones para suministrar peptido yy y agonistas de pyy. |
| EP1773376A4 (en) | 2004-08-03 | 2009-07-01 | Emisphere Tech Inc | ANTIDIBLE ORAL INSULIN BIGUANIDE COMBINATION |
| EP1781257B1 (en) * | 2004-08-13 | 2018-12-19 | Emisphere Technologies, Inc. | Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent |
| AU2005321803B2 (en) | 2004-12-29 | 2012-02-09 | Emisphere Technologies, Inc. | Pharmaceutical formulations of gallium salts |
| US8110547B2 (en) | 2005-01-12 | 2012-02-07 | Emisphere Technologies, Inc. | Compositions for buccal delivery of parathyroid hormone |
| KR101346902B1 (ko) | 2005-07-09 | 2014-01-02 | 아스트라제네카 아베 | 당뇨병 치료에 있어 glk 활성화제로서 사용하기 위한헤테로아릴 벤즈아미드 유도체 |
| WO2007011958A2 (en) | 2005-07-15 | 2007-01-25 | Emisphere Technologies, Inc. | Intraoral dosage forms of glucagon |
| WO2007121318A2 (en) | 2006-04-12 | 2007-10-25 | Emisphere Technologies, Inc. | Formulations for delivering insulin |
| US8771712B2 (en) | 2006-05-09 | 2014-07-08 | Emisphere Technologies, Inc. | Topical administration of acyclovir |
| JP5475443B2 (ja) | 2006-06-28 | 2014-04-16 | エミスフェアー・テクノロジーズ・インク | 硝酸ガリウム製剤 |
| JP5577094B2 (ja) * | 2006-08-31 | 2014-08-20 | エミスフェアー・テクノロジーズ・インク | 活性薬剤を送達するための化合物及び組成物 |
| BRPI0716261A2 (pt) | 2006-08-31 | 2013-08-06 | Novartis Ag | composiÇÕes farmacÊuticas compreendendo hch para distribuiÇço oral |
| JP5544169B2 (ja) * | 2007-02-08 | 2014-07-09 | エミスフェアー・テクノロジーズ・インク | フェニルアルキルカルボン酸誘導体送達剤 |
| US20110039930A1 (en) | 2009-08-03 | 2011-02-17 | Emisphere Technologies, Inc. | Fast-acting naproxen composition with reduced gastrointestinal effects |
| AU2011213175A1 (en) * | 2010-02-04 | 2014-02-20 | Michael M. Goldberg | Use of oral heparin preparations to treat urinary tract diseases and conditions |
| CN104758936A (zh) * | 2015-03-11 | 2015-07-08 | 苏州维泰生物技术有限公司 | 能输送生物活性物质的合成小分子化合物及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2517229A1 (de) * | 1975-04-18 | 1976-10-28 | Boehringer Mannheim Gmbh | Phenylalkylcarbonsaeure-derivate und verfahren zu ihrer herstellung |
| FR2374910A1 (fr) | 1976-10-23 | 1978-07-21 | Choay Sa | Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations |
| US4757066A (en) * | 1984-10-15 | 1988-07-12 | Sankyo Company Limited | Composition containing a penem or carbapenem antibiotic and the use of the same |
| AU610083B2 (en) | 1986-08-18 | 1991-05-16 | Clinical Technologies Associates, Inc. | Delivery systems for pharmacological agents |
| US5541155A (en) * | 1994-04-22 | 1996-07-30 | Emisphere Technologies, Inc. | Acids and acid salts and their use in delivery systems |
| JPH05239021A (ja) | 1990-09-04 | 1993-09-17 | Microbial Chem Res Found | 新規なアクチノニン誘導体 |
| HU211995B (en) * | 1992-06-30 | 1996-01-29 | Gyogyszerkutato Intezet | Process to prepare novel benzoyl amino acid derivs. and pharmaceutical compns. contg.them |
| US5643957A (en) * | 1993-04-22 | 1997-07-01 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US5650386A (en) | 1995-03-31 | 1997-07-22 | Emisphere Technologies, Inc. | Compositions for oral delivery of active agents |
| IL126318A (en) * | 1996-03-29 | 2004-09-27 | Emisphere Tech Inc | Compounds and compositions for delivering active agents and some novel carrier compounds |
-
1998
- 1998-02-06 AT AT99117292T patent/ATE383169T1/de active
- 1998-02-06 EP EP98905042.2A patent/EP1015008B1/en not_active Expired - Lifetime
- 1998-02-06 JP JP53503498A patent/JP4975201B2/ja not_active Expired - Fee Related
- 1998-02-06 CA CA2319672A patent/CA2319672C/en not_active Expired - Fee Related
- 1998-02-06 AT AT00122704T patent/ATE324907T1/de active
- 1998-02-06 NZ NZ337131A patent/NZ337131A/en not_active IP Right Cessation
- 1998-02-06 ES ES99117292T patent/ES2297909T3/es not_active Expired - Lifetime
- 1998-02-06 CA CA2319680A patent/CA2319680C/en not_active Expired - Fee Related
- 1998-02-06 PT PT00122704T patent/PT1093819E/pt unknown
- 1998-02-06 DK DK00122704T patent/DK1093819T3/da active
- 1998-02-06 EP EP99117292A patent/EP0993831B1/en not_active Expired - Lifetime
- 1998-02-06 CA CA2279331A patent/CA2279331C/en not_active Expired - Fee Related
- 1998-02-06 WO PCT/US1998/002619 patent/WO1998034632A1/en not_active Ceased
- 1998-02-06 EP EP00122704A patent/EP1093819B1/en not_active Expired - Lifetime
- 1998-02-06 ES ES00122704T patent/ES2263428T3/es not_active Expired - Lifetime
- 1998-02-06 DK DK99117292T patent/DK0993831T3/da active
-
2000
- 2000-10-03 NZ NZ507275A patent/NZ507275A/en not_active IP Right Cessation
- 2000-10-03 NZ NZ507276A patent/NZ507276A/en not_active IP Right Cessation
- 2000-10-11 JP JP2000311231A patent/JP3964613B2/ja not_active Expired - Fee Related
- 2000-10-11 JP JP2000311230A patent/JP4012679B2/ja not_active Expired - Fee Related